Correlation Between Anebulo Pharmaceuticals and Foghorn Therapeutics
Can any of the company-specific risk be diversified away by investing in both Anebulo Pharmaceuticals and Foghorn Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Anebulo Pharmaceuticals and Foghorn Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Anebulo Pharmaceuticals and Foghorn Therapeutics, you can compare the effects of market volatilities on Anebulo Pharmaceuticals and Foghorn Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Anebulo Pharmaceuticals with a short position of Foghorn Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Anebulo Pharmaceuticals and Foghorn Therapeutics.
Diversification Opportunities for Anebulo Pharmaceuticals and Foghorn Therapeutics
0.36 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Anebulo and Foghorn is 0.36. Overlapping area represents the amount of risk that can be diversified away by holding Anebulo Pharmaceuticals and Foghorn Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Foghorn Therapeutics and Anebulo Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Anebulo Pharmaceuticals are associated (or correlated) with Foghorn Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Foghorn Therapeutics has no effect on the direction of Anebulo Pharmaceuticals i.e., Anebulo Pharmaceuticals and Foghorn Therapeutics go up and down completely randomly.
Pair Corralation between Anebulo Pharmaceuticals and Foghorn Therapeutics
Given the investment horizon of 90 days Anebulo Pharmaceuticals is expected to under-perform the Foghorn Therapeutics. In addition to that, Anebulo Pharmaceuticals is 1.43 times more volatile than Foghorn Therapeutics. It trades about -0.17 of its total potential returns per unit of risk. Foghorn Therapeutics is currently generating about 0.05 per unit of volatility. If you would invest 764.00 in Foghorn Therapeutics on August 25, 2024 and sell it today you would earn a total of 20.00 from holding Foghorn Therapeutics or generate 2.62% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Anebulo Pharmaceuticals vs. Foghorn Therapeutics
Performance |
| Timeline |
| Anebulo Pharmaceuticals |
| Foghorn Therapeutics |
Anebulo Pharmaceuticals and Foghorn Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Anebulo Pharmaceuticals and Foghorn Therapeutics
The main advantage of trading using opposite Anebulo Pharmaceuticals and Foghorn Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Anebulo Pharmaceuticals position performs unexpectedly, Foghorn Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Foghorn Therapeutics will offset losses from the drop in Foghorn Therapeutics' long position.| Anebulo Pharmaceuticals vs. Adagene | Anebulo Pharmaceuticals vs. Acrivon Therapeutics, Common | Anebulo Pharmaceuticals vs. AnaptysBio | Anebulo Pharmaceuticals vs. Mineralys Therapeutics, Common |
| Foghorn Therapeutics vs. C4 Therapeutics | Foghorn Therapeutics vs. Prelude Therapeutics | Foghorn Therapeutics vs. Rezolute | Foghorn Therapeutics vs. Shattuck Labs |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Other Complementary Tools
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |